choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Betaseron

Betaseron Newsletter
  • MS Drug — Ampyra: A New Gait For Independence 24 Apr 2025 09:03 GMT

    … of Acorda Therapeutics, a biotechnology company based in Hawthorne, … : The typical MS drugs— the ABCs (Avonex, Betaseron/Betaferon, Copaxone … the formulation from Elan Pharmaceuticals, which continues to manufacture … access to the treatment. ampyra.com

  • Optum Rx Ends Reauthorization for Many Chronic Disease Drugs 19 Mar 2025 18:04 GMT

    … term condition Requires chronic treatment Long-term drug effectiveness is established … Kesimpta, Ocrevus/Zenovo, Mayzent, Betaseron, Copaxone, Glatopa, glatiramer acetate, Aubagio … for procedures and services in Medicare Advantage plans. The healthcare …

  • Rising Multiple Sclerosis Cases Drive Growth in the Betaferon/Betaseron Market Report 2025 04 Mar 2025 18:01 GMT

    … ? The Betaferon or Betaseron market has witnessed remarkable … Healthcare, an Algeria-based pharmaceutical company, entered into a … Betaferon for multiple sclerosis treatment. This collaboration is … , and improvements in medical research and development. …

  • Betaseron interactions: Alcohol, medications, and other factors 28 Feb 2025 14:06 GMT

    … ingredients, your doctor will likely not prescribe Betaseron. Treatment with the drug could cause … safe to take these medications together. Your doctor will likely give you … ’t been enough clinical trials to determine whether Betaseron is safe to …

  • Understanding Multiple Sclerosis: Types, symptoms, and treatment options 31 Jan 2025 04:17 GMT

    … ) Visual evoked potentials (VEP) Treatment Medication and therapies can help manage … as: Rebif Plegridy Extravia Betaseron Avonex Oral medication for RRMS include: … fingolimod(Gilenya) Intravenous (IV) infusion treatment for RRMS include: Ocrelizumab (Ocrevus …

  • Key Driver In The Betaferon Or Betaseron Global Market Report 2025:Rising Prevalence Of Multiple Sclerosis Drives Growth 22 Jan 2025 18:43 GMT

    … technological advancements, revolutionary drugs, digital health technologies, … deficiency. Betaferon or betaseron aids patients by … focus on the pharmaceutical and medical device sectors, partnered … a multiple sclerosis MS treatment. This partnership is …

  • Subcutaneous Biologics Market, Industry Trends And Global Forecasts To 2035: Subcutaneous Biologics Set To Transform Drug Delivery And Patient Adherence 16 Jan 2025 13:02 GMT

    … offering targeted treatments with minimal drug interactions. Historically … (Amgen) STELARA (Janssen Biotech) Trulicity (Eli Lilly) … Alteogen Foresee Pharmaceuticals SUBCUTANEOUS FORMULATION TECHNOLOGIES … / Abasaglar BENLYSTA Betaseron / Betaferon …

  • Betaseron dosage 03 Dec 2024 14:58 GMT

    … by the Food and Drug Administration (FDA) to treat: Betaseron is a biologic … taking Betaseron, your doctor will discuss your treatment plan with you. ACCESSIBLE DRUG LABELS … ’t take more Betaseron than your doctor prescribes. For some medications, taking more …

  • Betaseron (interferon beta-1b) 12 Aug 2024 13:22 GMT

    … on how to use Betaseron in the medication guide and instructions for … long-term treatment. If you and your doctor determine that Betaseron is safe … too much of this drug, call your doctor. You can also call …

  • Camerone Parker — A New Fashion Statement: Never Give Up! 23 May 2025 23:40 GMT

    … insurance to help with medical costs (one medication alone cost $65, … of so many new drugs and drug treatments, all of which are … i.e., supportive friends, excellent doctors whom you can always ask … s very good that the pharmaceutical companies are doing this. …

Satisfied with the content?

Continue to create your account.